Flynn James E 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-24 7:57 pm Sale |
2025-03-20 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Flynn James E | 10,514,657 10.720% |
-563,270 (-5.08%) |
Filing |
| 2022-11-18 5:06 pm Purchase |
2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Flynn James E | 11,077,927 11.810% |
11,077,927 (New Position) |
Filing |